Skip to content

Clinical trials

Completed Mesothelioma, Malignant trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Status: Completed Country / region: United States Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20015
20023
20035
20042
20052
20066
20076
20084
20092
20107
20112
20121
20131
20141
20152
20162
20175
20181
20192
20201
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
Memorial Sloan Kettering Cancer Center8
Alliance for Clinical Trials in Oncology6
M.D. Anderson Cancer Center5
Abramson Cancer Center at Penn Medicine3
Roswell Park Cancer Institute3
University of Pennsylvania3
Barbara Ann Karmanos Cancer Institute2
Dana-Farber Cancer Institute2
Fox Chase Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant80
Carcinoma, Non-Small-Cell Lung19
Solitary Fibrous Tumor, Pleural16
Lung Neoplasms13
Mesothelioma12
Pancreatic Neoplasms10
Colonic Neoplasms9
Small Cell Lung Carcinoma9
Breast Neoplasms8
Carcinoma, Ovarian Epithelial8

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.